TissUse GmbH

TissUse is a Berlin, Germany-based, biotechnology company, which has developed a unique Multi-Organ-Chip platform that provides unparalleled preclinical insight on a systemic level using human tissues. This enabling technology platform consists of a miniaturized construct that closely simulates the activity of multiple human organs in their true physiological context. TissUses Multi-Organ-Chips provide a new approach to predict, for example, toxicity, ADME profiles and efficacy in vitro, reducing and replacing laboratory animal testing and streamlining human clinical trials. TissUses Multi-Organ-Chips have been utilized in a large variety of applications including drug development, cosmetics, food and nutrition and consumer products since 2012....

Biotechnology,organ-on-a-chip,body-on-a-chip,tissue engineering,microfluidics,assay development,patient-on-chip,microphysiological system,organoids,contract assay development,drug development,disease modelling,pharma,toxicology,pharmacokinetics,pharmacodynamics,ipsc,automation,ai,and cell culture

Tissuse gmbh operates in the Biotechnology research industry.

Tissuse gmbh's revenue is 1m - 10m

Tissuse gmbh has 11 - 50 employees.